Pain Medicine, Interventional Pain Medicine · West Palm Beach, FL
NPI
1003249566
Since 2013
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3222 Commerce Pl Ste A
West Palm Beach, FL, 33407
Phone (772) 267-9276
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
4,074 services
Medicare patients, 2024
160
Average age 67
Drug cost, 2024
$1.2M
7,983 prescriptions
Company payments, 2025
$1,257
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D Beelitz was code 99213 (office e&m - established), 932 times for 134 patients. In total John D Beelitz billed 4,074 services in 39 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 932 | 134 | $64.16 | $60K |
| 96136 Behavioral Health Services | Office | 612 | 133 | $29.27 | $18K |
| 96137 Behavioral Health Services | Office | 611 | 133 | $26.56 | $16K |
| 98980 Care Management/Coordination | Office | 437 | 85 | $40.42 | $18K |
| 98981 Care Management/Coordination | Office | 427 | 67 | $32.09 | $14K |
| 99214 Office E&M - Established | Office | 275 | 122 | $87.18 | $24K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 223 | 99 | $65.01 | $14K |
| 98975 Pulmonary | Office | 77 | 77 | $16.00 | $1,232 |
| 99215 Office E&M - Established | Office | 41 | 33 | $137.44 | $5,635 |
| 99204 Office E&M - New | Office | 21 | 21 | $109.81 | $2,306 |
| 99205 Office E&M - New | Office | 19 | 19 | $159.76 | $3,036 |
By year: 2022 $130K for 1,056 services; 2023 $172K for 2,148 services; 2024 $202K for 4,074 services.
Medicare prescription drug claims, 2024
In 2024, the drug John D Beelitz prescribed most often to Medicare patients was Oxycodone Hcl, with 1,394 prescriptions and refills. In total John D Beelitz wrote 7,983 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,394 | 1,399 | 155 | $35K |
| Morphine Sulfate Er Morphine Sulfate | 955 | 958 | 105 | $41K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 715 | 725 | 94 | $28K |
| Gabapentin Generic | 516 | 586 | 104 | $8,895 |
| Methadone Hcl Generic | 282 | 284 | 36 | $5,743 |
| Oxycontin Oxycodone Hcl | 265 | 274 | 28 | $336K |
| Morphine Sulfate Generic | 263 | 263 | 32 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 215 | 215 | 32 | $5,750 |
| Movantik Naloxegol Oxalate | 195 | 219 | 73 | $88K |
| Fentanyl Generic | 183 | 183 | 29 | $31K |
| Pregabalin Generic | 181 | 193 | 48 | $4,680 |
| Cyclobenzaprine Hcl Generic | 174 | 184 | 30 | $2,208 |
| Baclofen Generic | 169 | 203 | 50 | $1,437 |
| Hydromorphone Hcl Generic | 166 | 166 | 26 | $5,244 |
| Duloxetine Hcl Generic | 165 | 227 | 41 | $1,792 |
Brand drugs: 963 claims; generic drugs: 7,020 claims; opioid claims: 4,769.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D Beelitz $1,257 ($1,257 in general payments such as food, travel and fees) from 7 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $777.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 44 | $777 |
| Valinor Pharma, LLC | 15 | $183 |
| Collegium Pharmaceutical, Inc. COLL | 12 | $144 |
| Globus Medical, Inc. GMED | 2 | $55.18 |
| Protega Pharmaceutials Inc | 3 | $51.11 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $24.58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $21.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.